Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kiora Pharmaceuticals Inc. (KPRX)

Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiora Pharmaceuticals Inc. 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024 USA

www.kiorapharma.com Employees: 12 P: 858-224-9600

Sector:

Medical

Description:

Kiora Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company. It involved in developing and commercializing products for treating ophthalmic diseases. The company's product pipeline includes KIO-301, KIO-101 and KIO-201. Kiora Pharmaceuticals Inc., formerly known as EyeGate Pharmaceuticals Inc., is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 7,944
Enterprise Value, $K 4,154
Shares Outstanding, K 3,678
Annual Sales, $ 16,020 K
Annual Net Income, $ 3,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ 30 K
EBIT, $ -8,080 K
EBITDA, $ -7,960 K
60-Month Beta -0.75
% of Insider Shareholders 0.05%
% of Institutional Shareholders 76.97%
Float, K 3,676
% Float 99.95%
Short Interest 18
Short Float 0.50%
Short Volume Ratio 0.45

Growth:

1-Year Return -33.94%
3-Year Return -93.00%
5-Year Return -99.88%
5-Year Revenue Growth 495.54%
5-Year Earnings Growth 100.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 11/07/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -2.09
EPS Growth vs. Prev Qtr 101.85%
EPS Growth vs. Prev Year 101.23%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 06/11/24

KPRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -36.35%
Return-on-Assets % -25.82%
Profit Margin % 22.41%
Debt/Equity 0.00
Price/Sales 0.50
Price/Cash Flow 1.74
Price/Book 0.33
Book Value/Share 6.53
Interest Coverage 284.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar